SCM
OACC

Shaolin Capital Management’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Shaolin Capital Management’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.33M Sell
314,990
-60,010
-16% -$639K 0.12% 133
2025
Q4 		$3.97M Buy
375,000
+24,134
+7% +$255K 0.12% 114
2025
Q3 		$3.69M Buy
350,866
+156,104
+80% +$1.63M 0.16% 97
2025
Q2 		$2.04M Sell
194,762
-55,238
-22% -$573K 0.07% 98
2025
Q1 		$2.56M Sell
250,000
-300,000
-55% -$3.01M 0.09% 61
2024
Q4 		$5.48M Buy
+550,000
New +$5.49M 0.12% 60

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Shaolin Capital Management's OACC Position: Q1 2026 in Review

Shaolin Capital Management reduced its Oaktree Acquisition Corp III Life Sciences (OACC) stake by 16% in Q1 2026, selling an estimated $639K and leaving 314,990 shares worth $3.33M. The position accounts for 0.12% of the portfolio, ranked #133.

Shaolin Capital Management first reported a position in OACC in Q4 2024 and has held it in 6 quarters since. The position peaked at $5.48M in Q4 2024. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • Shaolin Capital Management held 314,990 shares of Oaktree Acquisition Corp III Life Sciences worth $3.33M as of Q1 2026.
  • Shaolin Capital Management sold 60,010 Oaktree Acquisition Corp III Life Sciences shares in Q1 2026, an estimated $639K.
  • Oaktree Acquisition Corp III Life Sciences made up 0.12% of Shaolin Capital Management's portfolio in Q1 2026, its #133 holding.
  • Shaolin Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • Shaolin Capital Management's Oaktree Acquisition Corp III Life Sciences position peaked at $5.48M in Q4 2024.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on Shaolin Capital Management's 13F filing for Q1 2026, filed 15 May 2026.